CBP Delays Implementation of Rule Restricting Imported Prescription Drugs

U.S. Customs and Border Protection (CBP) has announced a 90-day delay in the implementation of a new rule that would impose stricter import processes and documentation requirements for prescription drugs. This decision follows requests from over 70 members of Congress who expressed concerns about the potential negative impact on millions of Americans relying on lower-priced imported medications.